JENDMYA
Live / Applied — Second extension granted (statement of use) (as of 19 Feb 2026)
What this means for you
Not registered yet, but its 12 Aug 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98694886
- Mark type
- Stylized text
- Filed
- 12 Aug 2024
- Published for opposition
- 04 Feb 2025
- Attorney of record
- Cynthia Smuzynska
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of cancer; pharmaceutical and biological preparations for use in immunotherapy, in particular, T-Cell immunotherapy; pharmaceutical preparations for the treatment of oncological and blood disorders
Owner
- Kite Pharma, Inc., Santa Monica, CA, US
- Kite Pharma, Inc., Santa Monica, CA, US
Prosecution history
- 20 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Feb 2026 — SOU EXTENSION 2 GRANTED
- 19 Feb 2026 — SOU EXTENSION 2 FILED
- 19 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 14 Aug 2025 — SOU EXTENSION 1 GRANTED
- 14 Aug 2025 — SOU EXTENSION 1 FILED
- 14 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 01 Apr 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 04 Feb 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Feb 2025 — PUBLISHED FOR OPPOSITION
- 29 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 Jan 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Jan 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE